Research on antibiotics and the bacteria they target. Covers antibiotic resistance, gut pathogens, persistent strep throat, and water-source contamination.
Researchers have developed a wearable sensor patch capable of continuously monitoring vancomycin levels, a critical antibiotic used to treat severe bacterial infections. The sensor system detects changes in vancomycin concentration using aptamers and gold wires, providing real-time measurements for effective treatment.
A University of Melbourne research team is developing an oral therapeutic to restore the activity of common antibiotics used to treat community-acquired bacterial pneumonia. The project aims to combat antibiotic-resistant bacteria and reduce healthcare costs, with potential applications in low- and middle-income countries.
Researchers at the University of Sheffield have discovered a genetic scar that enables pneumonia-causing bacteria to become resistant to antibiotics. The study found that mutations in the pde1 gene act as an evolutionary gateway for this resistance, threatening patient treatment and highlighting the need for control measures.
Researchers have discovered a new plasmid in epidemic Vibrio cholerae samples that introduces genes encoding resistance to multiple antibiotics. The finding underscores the importance of genomic surveillance and suggests that the strain's stability poses a concerning factor for future outbreaks.
Researchers developed an integrated microfluidic chip for rapid antimicrobial susceptibility testing from positive blood cultures, reducing diagnosis time to under 3.5 hours. The chip demonstrated high accuracy in diagnosing clinical cases with a 93.3% agreement rate.
Researchers at Linköping University develop a new method to deliver strong compounds specifically to bacteria, allowing for efficient and safe treatment of infections. The TOUCAN strategy uses nucleases to target bacterial DNA, reducing side effects associated with current antibiotics.
Researchers at the University of Exeter found that certain antibiotics can alleviate stress and help prevent bacterial decline, allowing more bacteria to survive longer. The study, published in PNAS, suggests that these drugs can promote bacterial longevity and growth efficiency.
Researchers found that patients prescribed amoxicillin-clavulanate had higher rates of gastrointestinal symptoms and yeast infections than those prescribed amoxicillin. The study showed no difference in treatment failure rates between the two antibiotics, with treatment failure occurring in less than 2% of cases.
The September issue of the CHEST journal features research on long COVID, including a review on exercise pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2. Original studies also explore asthma treatment with albuterol-budesonide inhalers and sleep therapy using oronasal masks.
Researchers use genomic surveillance to identify distinct sexual networks for syphilis transmission in England, highlighting the presence of drug resistance. The study reveals information beyond standard epidemiological surveillance data, aiding public health strategies to break transmission chains.
A survey of 10,981 US adults found that toxic molds, fossil fuels, and antibiotics are common causes of chemical intolerance. The study suggests that reducing exposure to mold, pesticides, and other contaminants may help prevent future cases.
Researchers have made a significant advancement in the synthesis of β-lactam scaffolds, structural components frequently found in essential antibiotics. The breakthrough uses nickel catalysts to overcome challenges in β-lactam synthesis, enabling more efficient and simplified production of high-value materials.
A new powerful antibiotic, Clovibactin, has been discovered that can combat harmful bacteria and multi-resistant superbugs. It targets three different precursor molecules essential for bacterial cell wall synthesis, making it difficult for bacteria to develop resistance.
Researchers from the University of Bonn and international partners have discovered a new antibiotic called clovibactin that effectively attacks the cell wall of bacteria, including multi-resistant 'superbugs'. The compound has been shown to target bacterial cell wall components with high specificity, minimizing resistance development.
A new study reveals that using big data and machine learning can improve antimicrobial resistance surveillance in livestock production. The research found correlations between environmental variables, microbial communities, and antimicrobial resistance, suggesting multiple routes for improving surveillance.
Researchers at the University of Pennsylvania School of Engineering and Applied Science have discovered dozens of small protein sequences with antibiotic qualities in extinct organisms like Neanderthals and Denisovans. They then synthesized these molecules using artificial intelligence and tested their efficacy against pathogens.
The researcher aims to bridge completeness, efficiency, and applications in 3D graphs to solve problems in physics, fluid dynamics, and biotechnology. Geometric graphs can represent molecules, proteins, and drugs, enabling the prediction of their behavior and properties.
Researchers develop single-use nanoscale system that targets specific bacterium causing ear infections, eliminating most cases without antibiotic use. The system uses hypohalous acid similar to bleach and has shown promise in tests on chinchillas, with potential for future adaptation to prevent recurrent infections.
A new imaging method developed by UC researchers can identify specific lung infections in real time, reducing diagnosis time from 2-3 days to hours. The method uses injectable probes that light up under a nuclear imaging machine, enabling faster treatment for critically ill patients.
A new study reveals that bacterial resistance to albicidin is caused by an increase in the number of copies of a specific gene, leading to up to a 1,000-fold increase in resistance. This discovery highlights the growing threat of antibiotic resistance and underscores the need for effective strategies to combat it.
A new antibiotic strategy has been found to defeat gram-negative bacteria like Salmonella and E. coli by interfering with the outer lipid layer of the bacteria. The compound, LPC-233, is a small molecule that works fast and is durable in animal tests, with potentially vital applications against stubborn urinary tract infections.
Researchers used phage PASA16 to treat tough Pseudomonas aeruginosa infections, achieving an impressive 86.6% success rate. The study demonstrated the potential effectiveness of phage therapy as a valuable alternative to conventional antibiotics in combating antibiotic-resistant pathogens.
A new study suggests that controlling air pollution could reduce antibiotic resistance, which is responsible for 480,000 premature deaths annually. The analysis indicates a significant link between PM2.5 levels and antibiotic resistance globally.
Researchers at the University of Tokyo have developed a continuous-flow manufacturing method for producing cefazolin, an essential antibiotic. This new approach reduces time, cost and waste, making it ideal for flexible production and improving global health access.
Researchers find that Acinetobacter baumannii can achieve significant functional modifications in protein complexes over short evolutionary time spans, particularly in hair-like cell appendages. This diversity may affect the pathogen's interaction with its environment and inform personalized therapies.
A recent study discovered the complex circadian clock mechanisms in soil bacteria Bacillus subtilis, regulating multiple genes and behaviors. The findings have significant implications for industrial applications, human health, and plant science.
Scientists have developed a new liquid metal coating that can treat and kill bacteria, offering a potential solution to the growing threat of antimicrobial resistance. The coating, made from gallium liquid metal particles, has improved biocompatibility and low cytotoxicity, making it safe for human cells.
Researchers have discovered a new way to combat fatal fungal infections by blocking the production of fatty acids, a major component of fats. The breakthrough could lead to more effective treatments against species-resistant fungi.
A team of researchers at the University of Oklahoma has made a groundbreaking discovery in overcoming antimicrobial resistance by developing a new class of molecules that inhibit efflux pumps. These inhibitors work as 'molecular wedges' targeting the area between bacterial cell membranes, increasing the effectiveness of antibiotics.
Researchers at UMass Amherst have discovered a potential new medical therapy for Lyme disease using lactate dehydrogenase inhibitors typically used to combat cancer. The study found that these inhibitors substantially impacted Borrelia burgdorferi growth, making them promising candidates against Lyme infections.
Researchers at the University of Copenhagen have discovered how a bacterium called Vibrio alginolyticus moves using sodium ions, which could lead to new targets for antibiotics. The study provides insights into the flagellum's movement and may help develop novel antibiotics to combat antibiotic resistance.
A meta-analysis of 221 randomized controlled trials reveals oral isotretinoin as the most effective treatment for acne, followed by triple therapies containing antibiotics and retinoids. The study also found that monotherapies like antibiotics and retinoids have comparable efficacy for inflammatory lesions.
A new study suggests that bacterial testing in children with sinusitis could greatly reduce unnecessary antibiotic use. By identifying which children are likely to benefit from antibiotics, doctors can avoid prescribing medications to those who wouldn't see improvement in symptoms.
Female beewolves release toxic nitric oxide to kill mold fungi in brood cells, but their symbiotic bacteria are protected by hydrocarbons secreted from their antennae. These hydrocarbons block the diffusion of nitric oxide and prevent bacterial harm.
A report from University of Queensland researchers highlights promising developments in new antibiotics, with 62 in development. However, experts warn that current pace is not enough to avoid a crisis due to rising deaths from resistant bacteria, with potential solutions including subscription payment models and non-antibiotic approaches.
Researchers at ETH Zurich have developed a rapid test that detects bladder infections using bacteriophages, which can identify the pathogenic bacteria in under four hours. The test also allows for tailored phage therapy, predicting patient response and increasing treatment effectiveness.
Researchers at IISc designed a short peptide that targets topoisomerases in disease-causing bacteria, including antibiotic-resistant species. The peptide effectively killed bacterial cells and reduced infection in animal models, providing leads for combination therapy with existing antibiotics.
A novel stress signalling system has been discovered by SMART researchers, enabling bacteria cells to adapt and survive against the immune system and certain antibiotics. The breakthrough discovery of RlmN as a stress sensor may lead to the development of new therapies to combat antimicrobial resistance.
Researchers developed a novel metal-derived complex to treat Avian Pathogenic Escherichia coli (APEC), a serious respiratory infection resistant to antibiotics. The treatment, manganese carbonyl, showed protective effects in chickens with APEC, reducing bacterial shedding and killing.
Researchers at Tokyo University of Science successfully synthesized tanzawaic acid B in large amounts, paving the way for new antibiotic development. The breakthrough method could lead to creation of various compounds for pharmaceuticals, including new antibiotic candidates.
A recent study found that women with Lyme disease experience longer diagnostic delays, more severe symptoms, and increased misdiagnoses compared to men. The study also revealed no significant differences in antibiotic treatment response or side effects.
The study identified significant differences in antibiotic resistance trends and associated factors depending on bacterial species and antibiotic resistance to certain antibiotics. High health system quality was linked to low levels of resistance, while high temperatures were associated with increased resistance in Enterobacteriaceae.
A new study led by Vanderbilt University Medical Center has shown that a simple direct oral challenge can safely remove penicillin allergy labels from low-risk patients. This method performs as well as traditional skin testing and oral challenges, with no serious adverse events reported.
Researchers discuss treatment refractory forms of chronic sinusitis, highlighting the importance of interdisciplinary diagnostics and therapy. Fungal infections are a rare cause, yet crucial to consider when treating this condition.
A study published in the Journal of Hospital Infection reveals that pharmacist-led multi-faceted interventions can optimize antimicrobial prescriptions in dental clinics, reducing the incidence of serious infectious diseases. The intervention increased penicillin usage and decreased the use of broad-spectrum antimicrobials.
Researchers found that antimicrobial resistance emerges from selection for pre-existing resistant clones, not new mutations. Infections with multiple pathogen clones show increased resistance to antibiotics, but also potential for faster loss of resistance when no antibiotics are present.
Researchers have discovered a new target for antibiotics that could treat multi-drug resistant superbugs. The antibiotic AMC-109 affects the cell membrane of bacteria by disordering its organization, leading to the death of the bacterium. This approach may also break down resistance to old-fashioned antibiotics.
A recent study found that Kenyan patients who spend more than three days in hospitals are more likely to harbor antibiotic-resistant bacteria. The research team identified three risk factors associated with colonization, including hospitalization for extended periods and intubation.
Researchers identified a new drug treatment option for peritonitis in patients on peritoneal dialysis, showing that a low dosage of ceftazidime and avibactam is sufficient to treat the infection. The study's findings could help gain control over peritonitis in patients with difficult-to-treat germs.
Researchers discovered that using fat-free mass for gentamicin dosage calculation yields more effective results than traditional methods. This method is particularly beneficial for premature babies, who have weaker kidneys and require adjusted dosing.
A study published in Frontiers in Microbiology found that administering vaginal suppositories with Lactobacillus crispatus can restore a healthy balance of vaginal microbiota and prevent recurrent cystitis. The researchers discovered that postmenopausal women with RC had significantly different bacterial communities compared to those w...
Researchers discovered high levels of antibiotic resistance among war-wounded patients in Ukrainian hospitals, with nearly 10% resistant to colistin. The study highlights the challenges posed by resistant bacteria in times of war, particularly the highly resistant Klebsiella pneumoniae bacteria.
Researchers discovered how two new compounds attack TB-causing bacteria, providing insights into future therapies. The study found that one compound binds better to ATP synthase than existing treatment, while another targets a previously unknown site.
The updated guidance emphasizes the importance of antimicrobial stewardship to reduce MRSA infection rates. It also recommends surveillance for asymptomatic carriers and decolonization for those colonized with MRSA. Effective hand hygiene and cleaning practices remain crucial in preventing MRSA transmission.
Researchers at the University of California - Riverside have developed a low-cost technology using biochar to remove harmful compounds from reclaimed water, making it safe for agricultural reuse. The biochar-based polishing systems have shown promising results in removing antibiotics and resistant bacteria, potentially reducing the spr...
Researchers found that probiotics help preterm babies achieve a balanced gut microbiome and eradicate harmful bacteria. The study also shows that probiotic-supplemented preterm newborns have lower risk of carrying antimicrobial resistant bugs despite frequent antibiotic treatment.
A recent study published in JAMA found that continuous meropenem administration did not improve mortality rates or reduce the emergence of drug-resistant bacteria in critically ill patients with sepsis. The results suggest that intermittent administration may be a more effective treatment strategy for this condition.
Researchers at Nagoya University have discovered that targeting Fusobacterium bacteria can reduce the formation of lesions associated with endometriosis. The study suggests an effective non-hormonal antibiotic treatment for this gynecological disorder, which affects one in ten women between 15 and 49 years old.
A study found that even insured patients with diabetes use crowdfunding platforms like GoFundMe to cover excess medical expenses, including uncovered co-pays and life-saving care. Researchers urge policymakers to consider these needs when developing affordable diabetes care policies.
A statewide pay-for-performance intervention based on Choosing Wisely reduced rates of inappropriate antibiotic prescriptions for acute respiratory tract infections from 43% to 25%. This reduction occurred without measurable harms at safety-net hospitals serving disadvantaged patients.